Fiedler, W., Montesinos, P., Schliemann, C., Middeke, J., Vasu, S., Scholz, C. W., Esteve, J., Mondal, S., Rüter, B., Burkard, U., Osswald, A. and Blum, W. (2022) “An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemia”, Haematologica. Pavia, Italy, 107(12), pp. 2977-2982. doi: 10.3324/haematol.2022.281128.